Without pharmaceutical intervention, authorities must rely entirely on finding cases and isolating them.
In the Democratic Republic of Congo, a virus older than its current crisis is writing a new and troubling chapter. The Bundibugyo strain of Ebola — once a footnote in outbreak history — has become its largest recorded epidemic, with nearly 600 cases and more than 130 deaths since confirmation on May 15. What makes this moment particularly grave is not only the scale, but the absence of approved vaccines or treatments, leaving health authorities to rely on the oldest tools in medicine: finding the sick, isolating them, and tracing those they touched. The world watches, knowing that in an age of global travel, no outbreak is ever entirely someone else's.
- The Bundibugyo strain has no approved vaccine or antiviral treatment, forcing responders to fight a fast-moving hemorrhagic virus with contact tracing and isolation alone.
- Weeks of silent transmission — enabled by a long incubation period and initial testing for the wrong Ebola strain — allowed the outbreak to more than double in size before its true scope was understood.
- The DRC's simultaneous battles with mpox, measles, malnutrition, and malaria are overwhelming a fragile health system and obscuring Ebola cases within a fog of competing illness.
- At least four health workers have been infected, the outbreak has already crossed into Uganda, and WHO's declaration of a public health emergency of international concern signals that containment is urgent but far from assured.
- Emergency departments worldwide are being urged to strengthen travel-screening protocols, as history — from Lagos to Dallas — has shown that a single misdiagnosed traveler can seed new chains of transmission far from the source.
The Democratic Republic of Congo is now at the center of the largest Bundibugyo Ebola outbreak ever recorded. Since health authorities confirmed the outbreak on May 15, nearly 600 people have tested positive and more than 130 have died. The virus spreads through contact with blood and bodily fluids, and unlike the more familiar Zaire strain, the Bundibugyo variant has no approved vaccine and no proven drug treatment. The fatality rate sits near 30 percent. The WHO has sponsored trials of a monoclonal antibody and remdesivir, but neither is yet standard care.
The outbreak grew large before anyone fully grasped what was happening. Ebola's incubation period of two to three weeks allowed silent spread for weeks. Early warning signals appeared in April, with hemorrhagic fever reports dating to March — but initial testing targeted the wrong strain. By the time labs tested specifically for Bundibugyo, the outbreak had already more than doubled in size and crossed into Uganda. The DRC is simultaneously managing mpox, measles, malnutrition, and chronic malaria, all of which weaken immune systems and make Ebola harder to identify among the noise of other serious illness.
This is Bundibugyo's first epidemic-scale outbreak. Two previous events — Uganda in 2007 with 149 cases, the DRC in 2012 with 57 — were contained quickly. The current outbreak has surpassed both. Health workers are among the most exposed; at least four have been infected, including an American missionary doctor. Funeral practices that involve touching the dead carry particular risk, and the highest level of personal protection is essential for anyone near patients.
Containment now depends on the same measures that ended the 2014 West African epidemic before vaccines existed: rapid diagnosis, isolation, contact tracing, and — critically — community trust. In 2014, eight health workers were killed by locals who feared or distrusted the response, a reminder that technical capacity alone is not enough. The risk also extends beyond the region. During the 2014 epidemic, cases reached Nigeria and the United States; a misdiagnosed traveler in Texas led to four additional infections. Emergency departments worldwide need better systems to prompt staff to ask about recent travel and act quickly when the answer raises concern.
A longer shadow also falls over the recovery period. Ebola survivors can harbor the virus for months, transmitting it through certain bodily fluids long after they appear well. A large outbreak produces many survivors — and with them, the possibility that transmission continues quietly after the acute crisis seems to have passed. The WHO's declaration of a public health emergency of international concern brings additional resources, but the fundamental challenge remains: containing a fast-moving virus with limited infrastructure, no approved treatment, and a diagnostic system still struggling to keep pace.
The Democratic Republic of Congo is now home to the largest Ebola outbreak caused by the Bundibugyo strain ever recorded. Since health authorities confirmed the outbreak on May 15, case numbers have climbed steadily. Nearly 600 people have tested positive, and more than 130 have died. The virus moves through contact with blood and bodily fluids—vomit, feces, the fluids that seep from a body in the hemorrhagic stage. It can spread from contaminated surfaces, from touching the dead, and through routes that require no direct contact at all.
What makes this outbreak particularly difficult to contain is that the Bundibugyo strain, unlike the more common Zaire variant that devastated West Africa in 2014, has no approved vaccine and no proven drug treatment. The fatality rate hovers near 30 percent. The World Health Organization has sponsored trials of a monoclonal antibody and remdesivir, the antiviral used for COVID, but neither is yet available as standard care. Without pharmaceutical intervention, authorities must rely entirely on the measures that worked in 2014: finding cases, isolating them, tracing their contacts, and quarantining those exposed.
The outbreak grew so large so quickly because of a cascade of delays. Ebola has an incubation period of two to three weeks or longer, meaning infected people were spreading the virus silently for weeks before anyone knew what was happening. An early warning system detected signals of unknown illness on April 13, with reports of hemorrhagic fever dating back to March 13. But initial testing targeted the more common Zaire strain. When labs finally tested for Bundibugyo specifically, they discovered the outbreak was already more than double the size they had thought—and it had already crossed into Uganda. The DRC is simultaneously battling mpox and measles outbreaks, along with widespread malnutrition and chronic malaria. These conditions weaken immune systems and muddy the diagnostic picture, making it harder to spot Ebola cases among the noise of other serious illness.
This is the first time Bundibugyo has reached epidemic scale. Two previous outbreaks occurred—one in Uganda in 2007 with 149 cases, another in the DRC in 2012 with 57 cases. The current outbreak has already surpassed both. The 2014 West African Ebola epidemic, caused by the Zaire strain, infected more than 28,000 people and killed over 11,000. That outbreak happened before vaccines existed. The DRC's most recent Ebola outbreak, in late 2025, involved only 64 cases. The largest DRC outbreak on record before now was in 2018-2019, with more than 3,000 cases.
Health workers are among the most vulnerable. At least four have been infected, including an American missionary doctor. Funeral attendants and close family members face similar risk because Ebola spreads through direct contact with blood and bodily fluids, and funeral practices in the region often involve touching the body. The highest level of personal protection is essential for anyone in direct contact with patients.
Stopping the outbreak requires coordinated surveillance and containment. In 2014, when no treatments or vaccines existed, these measures alone brought the epidemic under control. The DRC must scale up its capacity to diagnose cases—testing is limited, so clinical case definitions can help identify probable cases when laboratory confirmation is not immediately available. Simple surveillance systems, including monitoring community reports and local news, can surface outbreaks early. Critically, health authorities must build trust with communities and community leaders. In 2014, locals killed eight Ebola health workers, a stark reminder that without community buy-in, containment fails.
The risk extends beyond the DRC and Uganda. Travel can carry the virus anywhere. During the 2014 West African epidemic, cases appeared in Nigeria and the United States. A misdiagnosed case in Texas led to four additional infections, including among health workers. Emergency departments worldwide need better tools: decision-support systems that prompt staff to ask about recent travel and alert them to disease outbreaks in countries patients have visited. A person with fever who recently traveled to an affected region should be isolated immediately, not sent back to a waiting room for hours.
Another long-term concern looms. Survivors of Ebola can harbor the virus for months or longer after recovery. If they come into contact with bodily fluids—semen, amniotic fluid, breast milk, placental fluid, eye secretions—they can still transmit the virus. An outbreak that grows large enough to produce many survivors could continue spreading long after the acute epidemic appears to end. The WHO's declaration of a public health emergency of international concern activates additional resources and measures, but the fundamental challenge remains: the DRC must contain this outbreak with limited health system capacity, no approved drugs, and a virus that moves faster than diagnosis can keep up.
Citas Notables
Health system capacity is the key to epidemic control. In 2014, these measures alone controlled the Ebola epidemic at a time when no treatments or vaccines were available.— UNSW Sydney biosecurity researchers
It's essential to communicate and work with communities and community leaders from the ground up. In 2014, locals murdered eight Ebola workers who provided health education, showing how important trust and community relationships are.— UNSW Sydney biosecurity researchers
La Conversación del Hearth Otra perspectiva de la historia
Why did it take so long to identify this as Ebola? The virus was circulating since March or April, but confirmation didn't come until May 15.
The DRC was looking for the wrong thing. Initial testing targeted the Zaire strain, which is far more common. Bundibugyo requires specific tests. By the time they switched approaches, the virus had already spread widely and crossed into Uganda.
So the outbreak was already massive by the time anyone knew what it was.
Exactly. Ebola has a two to three week incubation period. People were infected and infectious for weeks before symptoms appeared. When they finally tested for Bundibugyo, they realized the outbreak was more than twice the size they'd initially thought.
What makes this strain different from the Zaire variant that killed 11,000 people in 2014?
Bundibugyo is less lethal—around 30 percent fatality rate versus higher rates for Zaire. But here's the problem: there are no approved vaccines or drugs for Bundibugyo. In 2014, they had nothing either, but they still controlled it through isolation and contact tracing. Now we have those tools, but no pharmaceutical backup if the health system gets overwhelmed.
Can the same containment strategy work now?
In theory, yes. But the DRC is weaker than West Africa was in 2014. It's fighting mpox and measles simultaneously. Malnutrition is widespread. Health worker capacity is limited. And trust in health authorities is fragile—in 2014, locals killed eight Ebola workers. You can't contain an outbreak if communities won't cooperate.
What's the biggest risk to other countries?
Travel. A single infected person on a plane can start a chain of transmission anywhere. In 2014, a case in Texas led to four more infections before anyone realized what was happening. Emergency departments need better screening—asking about travel history, knowing which diseases are active in which countries, isolating patients before they infect staff and other patients.
And after the outbreak ends?
Survivors can carry the virus for months. If they have contact with bodily fluids—semen, breast milk, amniotic fluid—they can still transmit it. A large outbreak means many survivors, which means the risk of transmission continues long after the acute phase is over.